InspireMD is set to release its Q1 2026 financial results on May 4, 2026, with analysts projecting $2.70 million in revenue and an estimated -$0.19 EPS. The medical device company recently initiated a voluntary U.S. recall for its CGuard Prime 135 cm system due to performance issues, which may impact the upcoming financial report. Despite the recall, InspireMD reported a 53% increase in global unit sales and received FDA approval for its CGUARDIANS III study, while current financials show a strong current ...